Physician profile
Sophia L Fu
NPI 1205001013
$5,965.26
in general payments reported to CMS, 2019-2025
42 companies · $631 in 2025
The $631 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,047 · 2020: $484 · 2021: $485 · 2022: $373 · 2023: $1,991 · 2024: $955 · 2025: $631.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,646 · Travel and Lodging: $915 · Entertainment: $15.67.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,646.10 |
| Travel and Lodging | $915.05 |
| Entertainment | $15.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axogen | $2,042.92 | 2023-2025 | Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector |
| Carl Zeiss Meditec, INC. | $1,430.51 | 2019-2020 | |
| Hologic Sales and Service, LLC | $363.13 | 2023-2025 | Sentimag, Magtrace, Magseed |
| Endomagnetics LTD | $274.87 | 2024 | Magtrace, Magseed |
| Daiichi Sankyo INC. | $183.43 | 2021-2024 | Vanflyta |
| Kub Technologies INC. | $168.40 | 2022-2023 | Mozart |
| Merit Medical Systems INC | $159.54 | 2025 | Savi Scout |
| Lilly USA, LLC | $105.51 | 2020-2021 | |
| Gilead Sciences, INC. | $82.45 | 2022-2024 | Trodelvy |
| Innocoll Pharmaceuticals Limited | $80.91 | 2023 | Xaracoll |
| Tactile Systems Technology INC | $77.58 | 2023-2025 | Flexitouch Plus, Entre Plus, Nimbl |
| Stryker Corporation | $73.44 | 2024 | Spy-Phi System |
| Leica Microsystems INC. | $67.70 | 2020-2025 | Mammotome Revolve |
| Janssen Biotech, INC. | $66.72 | 2022-2023 | Erleada, Tecvayli, Darzalex |
| Karyopharm Therapeutics INC. | $65.38 | 2021 |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sophia Fu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.